On January 16, 2026, Morgan Stanley upgraded Rocket Lab from Equal Weight to Overweight, signaling growing confidence in the aerospace and defense company’s growth trajectory. The firm concurrently raised its price target from $67 to $105, representing the highest Street estimate. Analysts cited Rocket Lab’s expanding Electron launch manifest—with 24 missions secured through 2028—and the upcoming debut of its Neutron medium-lift vehicle as key catalysts for sustained revenue acceleration.

Over the past three months, Rocket Lab’s shares climbed approximately 45% following a reported 10% year-over-year increase in quarterly revenue, driven by a mix of commercial small-satellite launches and government contracts. This top-line expansion was paired with a 36% uplift in valuation multiples as investors reacted to a growing pipeline of launch orders and the company’s successful transition toward offering on-orbit services and propulsion systems for third-party spacecraft.